Clinical Trial Update: An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of simeprevir with sofosbuvir, with or without ribavirin, for recurrent genotype 1 hepatitis C after liver tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Hepatitits C | Phase 2 | Status: COMPLETED